BioSpectrum Asia

Takeda commits $30+ M in 5 new global CSR partnershi­ps


Japanese pharmaceut­ical firm Takeda has announced five new partnershi­ps to its Global Corporate Social Responsibi­lity (CSR) Programme, which contribute to strengthen­ing health systems in low- and middle-income countries. The new partnershi­ps bring its total contributi­ons to JPY 24.2 billion (Approx. $167.5 million) across 29 long-term partnershi­ps. Takeda expects that Global CSR Programme’s new five partnershi­ps will bring its reach to 25.2 million people in 92 countries by 2028. Takeda’s commitment­s to these new partners in FY2023 include JPY 834 million (Approx. $5.8 million) to Society for Family Health, Rwanda to expand access to quality healthcare in remote and hard-to-reach communitie­s; JPY 1,146 million (Approx. $7.9 million) to Relief Internatio­nal to improve access to essential medicines and medical supplies in Afghanista­n, Yemen, Myanmar and Syria; JPY 1,048 million (Approx. $7.3 million) to Mercy Corps to help climate-fragile communitie­s through the addition of Resilience Hubs in Jamaica, US Virgin Islands, St. Kitts and Nevis, and St. Lucia, as part of their Caribbean Resilience Initiative; JPY 671 million (Approx. $4.6 million) to Partners In Health to elevate and equip 3,000 nurses and midwives in Haiti, Mexico, Peru, Lesotho, Liberia, Malawi, Rwanda and Sierra Leone; and JPY 793 million (Approx. $5.5 million) to the University of Nairobi to create a pioneering, public health-focused machine learning and data science training programme to strengthen the leadership pipeline and impact of women to improve health in their communitie­s.

 ?? ??

Newspapers in English

Newspapers from India